Albert Boerla wins Genesis Prize 2022

Category : Awards Published on: January 22 2022

Share on facebook

The global pharmaceutical giant Pfizer Inc.’s Chairman and Chief Executive, Albert Bourla, has been awarded with the prestigious Genesis Prize 2022 on January 19, 2022.
He has been awarded for his efforts in leading the development of a COVID-19 vaccine (Pfizer–BioNTech COVID-19 vaccine).
The cash prize of this award is $1 million.
The annual prize is awarded to Jewish people who have achieved significant professional success, in recognition of their accomplishments, contributions to humanity, and commitment to Jewish values and/or to the State of Israel.
It is widely referred to as the “Jewish Nobel Prize”.

Railways launches ‘RailOne’ app as all-in-one digital platform for passengers
Read More....
Cabinet approves Employment Linked Incentive (ELI) scheme to boost job creation
Read More....
₹1 Lakh Cr RDI scheme approved to promote private innovation in key sectors
Read More....
Cabinet approves National Sports Policy 2025 to prepare for global sporting events
Read More....
Air Marshal S Sivakumar assumes charge as Air Officer-in-Charge Administration
Read More....
Ladakh hosts first Astro Tourism Festival to boost science-based tourism
Read More....
QUAD nations launch joint maritime observer mission under Wilmington Declaration
Read More....
G7 nations back ‘side-by-side’ global tax model for U.S. and UK companies
Read More....
Hero Motors files for ₹12 billion IPO to expand and reduce debt
Read More....
Kesavan Ramachandran appointed as Executive Director at RBI
Read More....